Skip to main content

Ganot Ilan's Form 4 filing

Solid Biosciences Inc. (SLDB) · filed Jan 30, 2026

Accession no.
0001193125-26-031765
Filed
Jan 30, 2026
Trade date
Jan 27-28, 2026
Filing delay
3 daysLate
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.26K. It was filed 3 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ganot IlanCIK 0001727460Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 27, 2026Common StockMOption exerciseAcquired+389–F1–17,667Indirect
Jan 28, 2026Common StockSSaleDisposed−191$6.59−$1,258.6917,476Indirect
Jan 27, 2026Common StockMOption exerciseAcquired+3,884–F1–99,297Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 27, 2026Common StockMOption exerciseDisposed−389$0.00$00Indirect
Jan 27, 2026Common StockMOption exerciseDisposed−3,884$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Restricted stock units convert into common stock on a one-for-one basis.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)